Is N-acetylcysteine effective in treating patients with coronavirus disease 2019? A meta-analysis

CH Chen, KF Hung, CY Huang, JL Leong… - Journal of the …, 2023 - journals.lww.com
Coronavirus disease 2019 (COVID-19) is a global pandemic caused by severe acute …
accumulated some evidence on the use of N-acetylcysteine (NAC) in treating patients with COVID-…

[HTML][HTML] The role of N-acetylcysteine in decreasing neutrophil-lymphocyte ratio in COVID-19 patients: A double-blind, randomized controlled trial

NA Prabowo, MA Megantara, H Apriningsih - Narra J, 2023 - ncbi.nlm.nih.gov
… , while the control group received standard care for COVID-19 and a placebo. The NLR …
used to compare the NLR before and after treatment while independent Student t-test was used

N-Acetylcysteine for COVID-19: a potential adjuvant therapy

M Elhidsi, F Fachrucha, RY Irawan - Journal of Health Sciences, 2021 - jhsci.ba
COVID19 and the role of N-acetyl cysteine (NAC) as a precursor of GSH and antioxidant
in adjuvant treatment of COVID-19. … influence the clinical application of NAC use in COVID-19. …

[HTML][HTML] N-acetylcysteine in severe COVID-19: The possible mechanism

MJ Hasan - International Journal of Infection, 2020 - brieflands.com
N-acetylcysteine (NAC), a relevant medication intended to use in the basic health system, and
it is generally used … also found in high levels in patients with severe COVID-19 (3, 4). NAC …

[HTML][HTML] N-acetylcysteine for the treatment of COVID-19 among hospitalized patients

SN Avdeev, VV Gaynitdinova, ZM Merzhoeva… - The Journal of …, 2022 - ncbi.nlm.nih.gov
… for the treatment of Novel coronavirus disease 2019 (COVID-19). … and improve prognosis
in patients with COVID-19. … retrospective cases series of COVID-19 patients that received an IL…

[HTML][HTML] … species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic …

A Nasi, S McArdle, G Gaudernack, G Westman… - Toxicology reports, 2020 - Elsevier
… Therefore, early treatment with anti-oxidants such as NAC during COVID-19 can be a way to
… the therapeutic use of anti-oxidant pharmaceutical interventions, such as N-acetylcysteine (…

[HTML][HTML] N-acetylcysteine as adjuvant therapy for hospitalized Covid-19 patients: A single-center prospective cohort study

S Afaghi, N Moghimi, NM Alamdari… - Caspian Journal of …, 2023 - ncbi.nlm.nih.gov
… Due to emergency use authorization for COVID-19 vaccines, the … COVID-19. It can reduce
hospitalization and mortality in COVID-19 patients who are unvaccinated or with no COVID-…

[PDF][PDF] Brief review of N-acetylcysteine as antiviral agent: potential application in COVID-19

E Dass - J Biomed Pharm Res, 2020 - researchgate.net
… of N-acetylcysteine (NAC), a Glutathione (GSH) precursor was undertaken to review its
potential use as antiviral agent, as adjuvant therapy in COVID 19, … N-acetylcysteine (NAC), the …

The effect of N-acetyl cysteine consumption on men with abnormal sperm parameters due to positive history of COVID-19 in the last three months

B Rafiee, SMB Tabei - Archivio Italiano di Urologia e …, 2021 - pagepressjournals.org
N-acetylcysteine (NAC), a derivative of amino acid L-cysteine, is used mainly as an antioxidant
(11). … the effect of NAC on abnormal sperm parameters in men with COVID 19 infection. …

Nacetylcysteine: a review of clinical usefulness (an old drug with new tricks)

GK Schwalfenberg - Journal of nutrition and metabolism, 2021 - Wiley Online Library
… The use of N-acetylcysteine should be considered in a number … In [103], recent reviews of
NAC and SARS-CoV-2 (COVID-19) … In a case report about one patient with severe COVID-19, …